Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.
Tao K, Yamazaki F, Kubo T, Sunami K, Kumamoto T, Arakawa A, Sugiyama M, Watanabe Y, Nakajima M, Shirakawa N, Tanimura K, Koyama T, Hirata M, Sudo K, Tanabe N, Watanabe T, Yoshida T, Kitami M, Yoshida A, Yatabe Y, Nakano Y, Ohira M, Kamijo T, Nakazawa A, Kato M, Ichimura K, Kohno T, Yamamoto N, Hishiki T, Ichikawa H, Ogawa C. Tao K, et al. Among authors: sugiyama m. JCO Precis Oncol. 2023 Jul;7:e2200266. doi: 10.1200/PO.22.00266. JCO Precis Oncol. 2023. PMID: 37410973
Evaluation of aprepitant and fosaprepitant in pediatric patients.
Saito Y, Kumamoto T, Arima T, Shirakawa N, Ishimaru S, Sonoda T, Nakajima M, Sugiyama M, Arakawa A, Hashimoto H, Makino Y, Ogawa C, Yamaguchi M. Saito Y, et al. Among authors: sugiyama m. Pediatr Int. 2019 Mar;61(3):235-239. doi: 10.1111/ped.13780. Epub 2019 Mar 5. Pediatr Int. 2019. PMID: 30615239
[Successful treatment of very severe late-onset sinusoidal obstruction syndrome with recombinant human soluble thrombomodulin, steroids, and control of intra-abdominal pressure].
Hirakawa T, Tanaka T, Matsumi J, Takeda W, Kim SW, Inamoto Y, Ito A, Yamaguchi K, Ishimaru S, Kumamoto T, Arakawa A, Sugiyama M, Dan L, Shigematsu M, Sato T, Ogawa C, Fukuda T. Hirakawa T, et al. Among authors: sugiyama m. Rinsho Ketsueki. 2020;61(7):734-739. doi: 10.11406/rinketsu.61.734. Rinsho Ketsueki. 2020. PMID: 32759558 Japanese.
Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
Fukuhara S, Oshikawa-Kumade Y, Kogure Y, Shingaki S, Kariyazono H, Kikukawa Y, Koya J, Saito Y, Tabata M, Yoshifuji K, Mizuno K, Miyagi-Maeshima A, Matsushita H, Sugiyama M, Ogawa C, Inamoto Y, Fukuda T, Sugano M, Yamauchi N, Minami Y, Hirata M, Yoshida T, Kohno T, Kohsaka S, Mano H, Shiraishi Y, Ogawa S, Izutsu K, Kataoka K. Fukuhara S, et al. Among authors: sugiyama m. Cancer Sci. 2022 Aug;113(8):2763-2777. doi: 10.1111/cas.15427. Epub 2022 Jun 17. Cancer Sci. 2022. PMID: 35579198 Free PMC article.
Surgical site infection caused by Rhizopus caespitosus after metastasectomy for osteosarcoma: First report of infection in humans.
Tanimura K, Nakajima M, Shirakawa N, Tao K, Sugiyama M, Watanabe Y, Arakawa A, Kikuchi M, Takahashi M, Narita Y, Shiotsuka M, Kobayashi O, Iwata S, Yoshida A, Abe M, Yamagoe S, Miyazaki Y, Ogawa C. Tanimura K, et al. Among authors: sugiyama m. Pediatr Blood Cancer. 2023 Apr;70(4):e30049. doi: 10.1002/pbc.30049. Epub 2022 Nov 1. Pediatr Blood Cancer. 2023. PMID: 36317667 No abstract available.
Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single-institution retrospective analysis.
Sugiyama M, Arakawa A, Shirakawa N, Tao K, Tanimura K, Nakajima M, Watanabe Y, Kumamoto T, Maniwa J, Yoneda A, Iwata S, Kobayashi E, Kawai A, Ogawa C. Sugiyama M, et al. Pediatr Blood Cancer. 2023 Jul;70(7):e30360. doi: 10.1002/pbc.30360. Epub 2023 Apr 19. Pediatr Blood Cancer. 2023. PMID: 37073613
2,486 results